Thyrocare IPO subscribed two times; Ujjivan 21%

Thyrocare Techonologies' initial public offering (IPO) has garnered 2.24 times subscription a day before close. The retail portion of the IPO has been subscribed 3.57 times, institutional investor portion has been subscribed 1.23 times and high net worth individual quota is subscribed 43%.

The medical diagnostics company's Rs 480-crore IPO closes on Friday. The price band for the IPO is Rs 420 to Rs 446 per share.

Read more from our special coverage on "IPO"

Meanwhile, Ujjivan Financial Services's IPO was subscribed 21% on the first day. The Rs 880-crore IPO by the small finance bank license holder's closes on Monday.

Ujjivan has set the price band for the IPO between Rs 207 and Rs 210 per share.


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel